Macrogenics SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 23, 2026, 4:05 p.m. ETView on SEC.gov
Other events · Financial statements and exhibits
AI summary, unreviewedMacroGenics Reports Interim Phase 1 MGC026 Data: 27% Best ORR in Heavily Pretreated SCCHN, No Discontinuations
4Oct. 7, 2026, 4:22 p.m. ETView on SEC.gov
8-K/ASept. 3, 2026, 4:39 p.m. ETView on SEC.gov
Financial statements and exhibits
4Aug. 20, 2026, 6:19 p.m. ETView on SEC.gov
4Aug. 18, 2026, 4:19 p.m. ETView on SEC.gov
SCHEDULE 13G/AAug. 14, 2026, 10:22 a.m. ETView on SEC.gov
10-QAug. 14, 2026, 4:19 p.m. ETView on SEC.gov
8-KAug. 13, 2026, 4:07 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
SCHEDULE 13G/AAug. 3, 2026, 4:18 p.m. ETView on SEC.gov
SCHEDULE 13GJuly 29, 2026, 3:19 p.m. ETView on SEC.gov